Anti-atherosclerotic effect of atorvastatin and clopidogrel alone and in combination in rats

Indian Journal of Experimental Biology

Volumn 46, Issue 10, 2008, Pages 698-703

  Srinivas, Martha ^a   Annapurna, Akula ^a   Reddy, Yellu Narsimha ^b  

^a ANDHRA UNIVERSITY   (India)

^b KAKATIYA UNIVERSITY   (India)

Author keywords

Atherosclerosis; Atorvastatin; Clopidogrel; Ldl

Indexed keywords

RATTUS;

ANTITHROMBOCYTIC AGENT; ATORVASTATIN; CLOPIDOGREL; DRUG DERIVATIVE; HEPTANOIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PYRROLE DERIVATIVE; TICLOPIDINE;

ANIMAL; ARTICLE; ATHEROGENIC DIET; ATHEROSCLEROSIS; BLOOD; DRUG INTERACTION; FEMALE; MALE; PATHOLOGY; RAT; WISTAR RAT;

ANIMALS; ATHEROSCLEROSIS; DIET, ATHEROGENIC; DRUG INTERACTIONS; FEMALE; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; PLATELET AGGREGATION INHIBITORS; PYRROLES; RATS; RATS, WISTAR; TICLOPIDINE;

EID: 58149373989     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Fuster V, Badimon L & Badimon J J, The pathogenesis of coronary artery disease and atherosclerosis, Circulation, 89 (1994) 36.
2. Wick G, Romen M, Amberger A, Metzler B & Mayr M, Atherosclerosis, autoimmunity, and vascular-associated lymphoid tissue, FASEB J, 11 (1997) 1199.
3. Hansson G K, Immune mechanisms in atherosclerosis, Arterioscler Thromb Vasc Biol, 21 (2001) 1876.
4. Shovman O, Levy Y, Gilburd B & Shoenfeld Y, Antiinflammatory and immunomodulatory properties of statins, Immunol Res, 25 (2002) 271.
5. Kroger K, Lindemann M, Kreuzfelder E, Brocker M, Santosa F & Grosse H, Effect of atorvastatin and clopidogrel on cellular immune function, Prostaglandins, Leukotrienes and Essential Fatty Acids, 68 (2003) 255.
6. Kritchevsky D, Tepper S A, Czarnecki S K & Sundram K, Red palm oil in experimental atherosclerosis, Asia Pacific J Clinic Nutrition, 11 (2002) 433.
7. Finking G, Nikolaj Nikolajewitsch Anitschkow established the cholesterol-fed rabbit as a model for atherosclerosis research, Atherosclerosis, 135 (1885-1964) 7.
8. Takahashi K, Takeya M & Sakashita N, Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals, Medical Electron Microscopy, 35 (2002) 179 .
9. Chandler R F, Hooper S N & Ismail H A, Antihypercholesterolemic studies with sterols: Comparison of rats and chicks as animal model, Can. J. Pharm. Sci, 68 (1979) 245.
10. Altman R F, A Simple method for the rapid production of atherosclerosis in rats, Experentia, 29 (1973) 256.
11. Philip D, Mayne, Diagnosis of renal dysfunction to clinical chemistry in diagnosis and treatment, ELBS, 1 (1994) 1.
12. Philip D, Mayne, Plasma lipid and lipoproteins to clinical chemistry in diagnosis and treatment, ELBS, 1 (1994) 223 .
13. Yagi K, A simple fluorimetric assay for lipid peroxides in blood plasma, Biochem Med, 15 (1976) 212.
14. Kohm H I & Liversedge M, During the induction of lipid peroxidation, J. Pharmacol, 82 (1944) 292.
15. Bridges A B, Mc Neill G P, Pringle T H & Belch J J, A late increase in free radical activity post myocardial infarction, Eur Heart J, 16 (1995) 899.
16. Friedman P J, Serum creatinine: An independent predictor of survival after stroke, J Intern Med, 229 (1991) 175.
17. Bajwa G S, Morrison L M & Ershoff B H, Induction of aortic and coronary athero-arteriosclerosis in rats fed a hypervitaminosis - D3, cholesterol containing diet, Proc Soc Exp Bio Med, 138 (1971) 975.
18. Ross R, Atherosclerosis-an inflammatory disease, N Engl J Med, 340 (1999) 115.
19. Brown B G, Zhao X Q, Sacco D E & Albers J J, Lipid lowering and plaque regression: New insights into prevention of plaque disruption and clinical events in coronary disease, Circulation, 87 (1993) 1781.
20. Michael H, Davidson, Niacin: A powerful adjunct to other lipid-lowering drugs in reducing plaque progression and acute coronary events, Curr Atherosclerosis Rep, 5 (2003) 418.
21. Wierzbicki A S, Atorvastatin, Expert Opinion Pharmacother, 2 (2001) 819.
22. Krause B R & Newton R S, Lipid-lowering activity of atorvastatin and lovastatin in rodent species: triglyceridelowering in rats correlates with efficacy in LDL animal models, Atherosclerosis, 117 (1995) 237.
23. Moghadasian M, Dietary phytosterols reduce probucolinduced atherogenesis in apo E-KO mice, Atherosclerosis, 188 (2003) 28.
24. Sinatra S T & De Marco J, Free radicals oxidative stress oxidative LDL and the heart, Conn Med, 59 (1995) 579.
25. Wannamethee S G, Shaper A G & Perry I J, Serum creatinine concentration and risk of stroke: A possible marker of increased risk for stroke, Stroke, 28 (1997) 557.
26. Shulman A G, Heparin and atherosclerosis an investigative report on the treatment of atherosclerosis, Biomed Pharmacother, 44 (1990) 303 .
27. Stemerman M B, Effects of moderate hypercholesterolemia on rabbit endothelium, Arteriosclerosis, 1 (1981) 25.